Skip to content
University of Maryland LibrariesDigital Repository at the University of Maryland
    • Login
    View Item 
    •   DRUM
    • A. James Clark School of Engineering
    • Fischell Department of Bioengineering
    • Fischell Department of Bioengineering Research Works
    • View Item
    •   DRUM
    • A. James Clark School of Engineering
    • Fischell Department of Bioengineering
    • Fischell Department of Bioengineering Research Works
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Induced pluripotent stem cell-derived cells model brain microvascular endothelial cell glucose metabolism

    Thumbnail
    View/Open
    s12987-022-00395-z.pdf (2.121Mb)
    No. of downloads: 5

    External Link(s)
    https://doi.org/10.1186/s12987-022-00395-z
    Date
    2022-12-09
    Author
    Weber, Callie M.
    Moiz, Bilal
    Zic, Sophia M.
    Vargas, Viviana Alpízar
    Li, Andrew
    Morss Clyne, Alisa
    Citation
    Weber, C.M., Moiz, B., Zic, S.M. et al. Induced pluripotent stem cell-derived cells model brain microvascular endothelial cell glucose metabolism. Fluids Barriers CNS 19, 98 (2022).
    DRUM DOI
    https://doi.org/10.13016/pmuk-p3tb
    Metadata
    Show full item record
    Abstract
    Glucose transport from the blood into the brain is tightly regulated by brain microvascular endothelial cells (BMEC), which also use glucose as their primary energy source. To study how BMEC glucose transport contributes to cerebral glucose hypometabolism in diseases such as Alzheimer’s disease, it is essential to understand how these cells metabolize glucose. Human primary BMEC (hpBMEC) can be used for BMEC metabolism studies; however, they have poor barrier function and may not recapitulate in vivo BMEC function. iPSC-derived BMEC-like cells (hiBMEC) are readily available and have good barrier function but may have an underlying epithelial signature. In this study, we examined differences between hpBMEC and hiBMEC glucose metabolism using a combination of dynamic metabolic measurements, metabolic mass spectrometry, RNA sequencing, and Western blots. hiBMEC had decreased glycolytic flux relative to hpBMEC, and the overall metabolomes and metabolic enzyme levels were different between the two cell types. However, hpBMEC and hiBMEC had similar glucose metabolism, including nearly identical glucose labeled fractions of glycolytic and TCA cycle metabolites. Treatment with astrocyte conditioned media and high glucose increased glycolysis in both hpBMEC and hiBMEC, though hpBMEC decreased glycolysis in response to fluvastatin while hiBMEC did not. Together, these results suggest that hiBMEC can be used to model cerebral vascular glucose metabolism, which expands their use beyond barrier models.
    URI
    http://hdl.handle.net/1903/29717
    Collections
    • Fischell Department of Bioengineering Research Works

    DRUM is brought to you by the University of Maryland Libraries
    University of Maryland, College Park, MD 20742-7011 (301)314-1328.
    Please send us your comments.
    Web Accessibility
     

     

    Browse

    All of DRUMCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister
    Pages
    About DRUMAbout Download Statistics

    DRUM is brought to you by the University of Maryland Libraries
    University of Maryland, College Park, MD 20742-7011 (301)314-1328.
    Please send us your comments.
    Web Accessibility